Long-term follow-up of allergic conjunctivitis in children: The out-patients' department experience (Allergic conjunctivitis in children: Management and care)

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 1, 2005, Pages 21-24

  Napoli, G ^a   Allegri, P ^a   Musso, C ^a   Morchio, A A ^a   Callegarini, L ^a   Murialdo, U ^a   Tanca, D ^a   Marre V ^a  

^a Hospital of Lavagna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CLOBETASONE; CYCLOSPORIN A; DEFLAZACORT; EMEDASTINE; EYE DROPS; FLUOROMETHOLONE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MIZOLASTINE; MONTELUKAST; PREDNISONE; STEROID;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; BLEPHARITIS; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORNEA ULCER; FEMALE; FOLLOW UP; HUMAN; KERATOCONJUNCTIVITIS; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PANNUS; PEDIATRICS; PHYSICAL EXAMINATION; PRICK TEST; RHINOCONJUNCTIVITIS; SLIT LAMP; TEAMWORK; TREATMENT PLANNING;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; CASE MANAGEMENT; CONJUNCTIVITIS, ALLERGIC; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; LEUKOTRIENE ANTAGONISTS; OPHTHALMIC SOLUTIONS; OUTPATIENT CLINICS, HOSPITAL; TREATMENT OUTCOME;

EID: 13544277474     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dinowitz M., Rescigno R., Bielory L. - Ocular allergic diseases: differential diagnosis, examination techniques and testing. Clin Allergy Immunol 2000;15:127-150.
2. Corsico R. - Rinocongiuntivite allergica. Boll Inf Medico-Statistiche 2001;100:1-16.
3. Belfort R., Marbeck P., Hsu C., Freitas D. - Epidemiological study of 134 subjects with allergic conjunctivitis. Acta Ophthalmol Scand 2000;78:18-21.
4. Bielory L.- Allergic disorders of the eye. St Louis: Mosby, 1996;976-987.
5. Friedlaender M.-H. - Current concepts in ocular allergy. Ann Allergy 1991;67:5-13.
6. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-421.
7. Allansmith M.-R. - The eye and immunology. St. Louis: Mosby, 1982.
8. Verin P., Comte P. - Classification of allergic conjunctivitis. Proceedings of the 8th Eur Congr of Ophthalmol, Lisbon, Ophthalmology Today. Amsterdam: Elsevier, 1989;495-497.
9. Irani A.-M. - Ocular mast cells and mediators in ocular allergy. In: Immunology and allergy clinics of North America. Philadelphia, 1997.
10. Ciprandi G., Buscaglia S., Pesce G. - Allergic subjects express intercellular adhesion molecule - 1 (ICAM 1 or CD 54) on epithelial cells. J Allergy Clin Immunology 1993;91:783-792.
11. Cvenkel B., Globocnik M. - Conjunctival scraping and impression cytology in chronic conjunctivitis. Eur J Ophthalmol 1997;7(1):19-23.
12. Bertel F., Mortemousque B. - Conjunctival provocation test. J Fr Ophtalmol 2001;24(6):581-589.
13. Bacon A.-S. - Tear and conjunctival changes during the allergen-induced early- and late- phase responses. J Allergy Clin Immunol 2000;106(5):948-954.
14. Bonini S., Ghinelli E. - The early and late phase of ocular allergic reaction. Acta Ophthalmol Scand 2000;230:41
15. Bielory L. - Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000;106(6):1019-32.
16. Leonardi A. - Role of histamine in allergic conjunctivitis. Acta Ophthalmol Scand 2000;78(230):18-21.
17. Abelson M.-B., Schaefer K. - Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993;38:115-32.
18. Allansmith M.-R., Ross R.-N. - Therapeutic review: ocular allergy and mast cells stabilizers. Surv Ophthalmol 1986; 30:229-244.
19. El-Defrawy S., Jackson W.-B. - New directions in the therapy for ocular allergy. Int Ophthalmol Clin 1996;36:25-44.
20. Smith E.-M. - Subjective and objective comparison of effects of fluorometholone acetate.and ketorolac eye-drops on CD54 expression in patients with allergic conjuctivitis. Invest Ophthalmol Vis Sci 1994;35:2217-2219.
21. Tuft S.-J., Kemeny E.-M., Dart JKG. - Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991;98:150-158.
22. Foster C.-S., Calonge M. - Atopic keratoconjunctivitis. Ophthalmology 1990;97:992-1000.
23. Rich L.-F., Hanifin J.-M. - Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 1985;25:61-76.
24. Tuft S.-J., Ramakrishnan M., Seal D.-V., Kemeny M., Buckley R.-J. - Role of Staphylococcus Aureus in chronic allergic conjunctivitis. Ophthalmology 1991;99:180-184.
25. Abelson M.-B., Madiwale N. - Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol 1983;101:555-556.
26. Berdy G.-J. - The effects of systemic medication on ocular allergic disease. Acta Ophthalmol Scand 2000;230:26-31.
27. Whitcup S.-M., Chan C.-C., Luyo D.-A., Bo P., Li Q. - Topical cyclosporine inhibits mast cell mediated conjunctivitis. Invest Ophthalmol Vis Sci 1996;37:2686-2693.
28. Bonini S., Centofanti M. - Allergic and non allergic mechanisms in the pathogenesis of vernal keratoconjunctivitis. Proceedings of Second Int Ophthalmol Workshop 1989, Paris.
29. Allansmith M.-R. - Vernal conjunctivitis. In: Duane System of Ophthalmol. Clinical Ophthalmology 1987;4:37-38.
30. Bonini S., Lambiase A., Schiavone M. - Vernal keratoconjunctivitis: a Th-2 driven disease? Proceedings of Am Ac Ophthalmol; San Francisco, 1994.
31. Anderson D.-F., Zhang S. - The relative contribution of mast cell subsets to conjunctival Th2-like cytokines. Invest Ophthalmol Vis Sci 2001;42(5):995-1001.
32. Tabbara KF: Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol 2001;119(3):338.
33. Verin P., Allewaert R. - Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis. Eur J Ophthalmol 2001;11(2):120-125.
34. Avunduk A.-M., Avunduk M.-C. - Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Ophthalmologica 2001; 215(4):290-293.
35. Secchi A., Tognon S., Leonardi A. - Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990;110:641-645.
36. Gupta V., Sahu P.-K. - Topical cyclosporine A in the management of vernal keratoconjunctivitis. Eye 2001;15:39-41.
37. Pandey S.-K., Saini J.-S., Werner L., Apple D.-J. - Mitomycin-C and vernal conjunctivitis. Ophthalmology 2000;107(12):2127.
38. Uchio E., Ono S.-Y., Ikezawa Z., Ohno S. - Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000;30:103-109.
39. Montan P.-G., Ekstrom K., Hedlin G., van Hage-Hamsten M., Hjem A., Hermann B. - Vernal keratoconjunctivitis in a Stockholm ophthalmic centre - epidemiological, functional and immunologic investigations. Acta Ophthalmol Scand 1999;77:559-563.
40. Uchio E., Ono S.-Y., Ikezawa Z., Ohno S. - Serum levels of soluble intercellular adhesion molecule-1, vascular adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis. Allergy 1999;54:135-141.
41. Secchi A., Leonardi A., Abelson M. - The role of eosinophil cationic protein (ECP) and istamine in vernal keratoconjunctivitis. Ocul Immunol Inflamm 1995;3:23-28.
42. Leonardi A., Borghesan R, Faggian D., Secchi A., Plebani M. - Eosinophil Cationic Protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610-613.
43. Leonardi A., Borghesan F., Faggian D., Depaoli M., Secchi A., Plebani M. - Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000;129:151-158.